Robert W. Baird Lowers Charles River Laboratories International (NYSE:CRL) Price Target to $173.00
Charles River Laboratories International (NYSE:CRL – Free Report) had its price target decreased by Robert W. Baird from $177.00 to $173.00 in a research note issued to investors on Thursday,Benzinga reports. Robert W. Baird currently has a neutral rating on the medical research company’s stock. A number of other research firms have also recently commented […]
Charles River Laboratories International (NYSE:CRL – Free Report) had its price target decreased by Robert W. Baird from $177.00 to $173.00 in a research note issued to investors on Thursday,Benzinga reports. Robert W. Baird currently has a neutral rating on the medical research company’s stock. A number of other research firms have also recently commented […]
